Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease

BACKGROUND: Knowledge of possible cardiovascular risks from Parkinson's disease (PD) medications is critical to informing safe and effective treatment decisions. The objective of our study was to determine whether PD patients treated with nonergot dopamine agonists (DAs) are at increased risk o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mov Disord Clin Pract
Päätekijät: Crispo, James A.G., Willis, Allison W., Thibault, Dylan P., Fortin, Yannick, Emons, Matthew, Bjerre, Lise M., Kohen, Dafna E., Perez‐Lloret, Santiago, Mattison, Donald, Krewski, Daniel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2015
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178630/
https://ncbi.nlm.nih.gov/pubmed/30363519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12286
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia